Papers
Topics
Authors
Recent
Gemini 2.5 Flash
Gemini 2.5 Flash
97 tokens/sec
GPT-4o
53 tokens/sec
Gemini 2.5 Pro Pro
44 tokens/sec
o3 Pro
5 tokens/sec
GPT-4.1 Pro
47 tokens/sec
DeepSeek R1 via Azure Pro
28 tokens/sec
2000 character limit reached

An optimal learning method for developing personalized treatment regimes (1607.01462v1)

Published 6 Jul 2016 in stat.ML and cs.LG

Abstract: A treatment regime is a function that maps individual patient information to a recommended treatment, hence explicitly incorporating the heterogeneity in need for treatment across individuals. Patient responses are dichotomous and can be predicted through an unknown relationship that depends on the patient information and the selected treatment. The goal is to find the treatments that lead to the best patient responses on average. Each experiment is expensive, forcing us to learn the most from each experiment. We adopt a Bayesian approach both to incorporate possible prior information and to update our treatment regime continuously as information accrues, with the potential to allow smaller yet more informative trials and for patients to receive better treatment. By formulating the problem as contextual bandits, we introduce a knowledge gradient policy to guide the treatment assignment by maximizing the expected value of information, for which an approximation method is used to overcome computational challenges. We provide a detailed study on how to make sequential medical decisions under uncertainty to reduce health care costs on a real world knee replacement dataset. We use clustering and LASSO to deal with the intrinsic sparsity in health datasets. We show experimentally that even though the problem is sparse, through careful selection of physicians (versus picking them at random), we can significantly improve the success rates.

User Edit Pencil Streamline Icon: https://streamlinehq.com
Authors (2)
  1. Yingfei Wang (20 papers)
  2. Warren Powell (8 papers)
Citations (8)

Summary

We haven't generated a summary for this paper yet.